(Q53621774)

English

The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

The effect of zoledronic acid and osteoprotegerin on growth of human lung cancer in the tibias of nude mice. (English)

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

zoledronic acid

1 reference

based on heuristic

inferred from title

Thomas J. Rosol

5

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

author name string

S H Tannehill-Gregg

1

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

A L Levine

2

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

M V P Nadella

3

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

H Iguchi

4

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

publication date

20 May 2006

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

Clinical & Experimental Metastasis

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

23

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

19-31

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

1

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

https://scigraph.springernature.com/pub.10.1007/s10585-006-9008-z

0 references

Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The basic biology of metastasis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New generation of bisphosphonates: broad clinical utility in breast and prostate cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of the bisphosphonate ibandronate on breast cancer metastasis to visceral organs

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitrogen-containing bisphosphonates inhibit cell cycle progression in human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer statistics, 2002

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advancing animal models of neoplasia through in vivo bioluminescence imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zoledronic acid exhibits inhibitory effects on osteoblastic and osteolytic metastases of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zoledronic acid: a review of its use in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RANKL/RANK/OPG: new therapeutic targets in bone tumours and associated osteolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of parathyroid hormone-related protein secretion and mRNA expression in normal human keratinocytes and a squamous carcinoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracrine PTHrP protects against serum starvation-induced apoptosis and regulates the cell cycle in MCF-7 breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates in the prevention and treatment of bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates and metastatic breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The distribution of secondary growths in cancer of the breast. 1889

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic review of bisphosphonates for hypercalcaemia of malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates inhibit breast and prostate carcinoma cell invasion, an early event in the formation of bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Messenger RNA stability of parathyroid hormone-related protein regulated by transforming growth factor-beta1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer and bone

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin/osteoclastogenesis inhibitory factor decreases human prostate cancer burden in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical practice. Hypercalcemia associated with cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced growth of MCF-7 breast cancer cells overexpressing parathyroid hormone-related peptide

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of bisphosphonates in breast and prostate cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor effects of bisphosphonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proven efficacy of zoledronic acid in the treatment of bone metastases in patients with breast cancer and other malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo visualization of metastatic prostate cancer and quantitation of disease progression in immunocompromised mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16715352

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10585-006-9008-Z

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/16715352

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53621774&oldid=1516348984"